Literature DB >> 11672464

Risk factors for toxoplasmic encephalitis in HIV-infected patients: a case-control study in Brazil.

L V Nascimento1, F Stollar, L B Tavares, C E Cavasini, I L Maia, J A Cordeiro, M U Ferreira.   

Abstract

A case-control study to identify the risk factors for toxoplasmic encephalitis (TE) among HIV-infected patients with latent Toxoplasma gondii infection was performed in a teaching hospital in south-eastern Brazil. Although the subjects were all positive for serum IgG antibodies to Toxoplasma, some (the cases) developed TE during routine follow-up at the hospital whereas others (the controls) did not. Adjusted odds ratios (aOR) were estimated by multiple logistic regression after controlling for potential confounders. Only 46 (22%) of the 210 cases but 93 (45%) of the 205 controls were on prophylactic regimens with co-trimoxazole [aOR = 0.30; 95% confidence interval (CI) = 0.15-0.60]. Subjects with fewer than 100 (aOR = 37.09; CI =7.49-183.67) or between 100 and 200 CD4 cells/microl (aOR = 10.20; CI =2.00-51.90) were at substantially increased risk of developing TE than those with >400 CD4 cells/microl. Although the results of preliminary, unadjusted data analysis indicated that male sex and homosexual or bisexual activity might be additional risk factors, these associations were not found to be statistically significant by multiple regression analysis. In conclusion, no risk factors for TE other than low CD4 cell counts and failure to receive prophylaxis were found among HIV-infected Brazilian patients with past exposure to Toxoplasma. Seropositive patients with CD4 cell counts above 100/microl (the point at which specific prophylaxis is usually recommended) but below 200/microl might also benefit from effective anti-TE prophylaxis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11672464     DOI: 10.1080/00034980120073931

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  6 in total

1.  Prevalence of Toxoplasma gondii infection in HIV-infected patients and food animals and direct genotyping of T. gondii isolates, Southern Ghana.

Authors:  Faustina Pappoe; Weisheng Cheng; Lin Wang; Yuanling Li; Dorcas Obiri-Yeboah; Samuel Victor Nuvor; Henock Ambachew; Xiaodong Hu; Qingli Luo; Deyong Chu; Yuanhong Xu; Jilong Shen
Journal:  Parasitol Res       Date:  2017-04-22       Impact factor: 2.289

Review 2.  Neurologic presentations of AIDS.

Authors:  Elyse J Singer; Miguel Valdes-Sueiras; Deborah Commins; Andrew Levine
Journal:  Neurol Clin       Date:  2010-02       Impact factor: 3.806

Review 3.  Toxoplasma gondii and the blood-brain barrier.

Authors:  Sabrina M Feustel; Markus Meissner; Oliver Liesenfeld
Journal:  Virulence       Date:  2012-03-01       Impact factor: 5.882

4.  Latent Toxoplasma gondii Infection and Associated Risk Factors among HIV-Infected Individuals at Arba Minch Hospital, South Ethiopia.

Authors:  Tsegaye Yohanes; Serkadis Debalke; Endalew Zemene
Journal:  AIDS Res Treat       Date:  2014-11-09

5.  Toxoplasmic Encephalitis in an AIDS Patient with Normal CD4 Count: A Case Report.

Authors:  Eissa Soleymani; Farhang Babamahmoodi; Lotfollah Davoodi; Amirkeivan Marofi; Peyman Nooshirvanpour
Journal:  Iran J Parasitol       Date:  2018 Apr-Jun       Impact factor: 1.012

6.  Toxoplasma encephalitis in HIV/AIDS patients admitted to the Douala general hospital between 2004 and 2009: a cross sectional study.

Authors:  Henry Namme Luma; Benjamin Clet Nguenkam Tchaleu; Yacouba Njankouo Mapoure; Elvis Temfack; Marie Solange Doualla; Marie Patrice Halle; Henry Achu Joko; Sinata Koulla-Shiro
Journal:  BMC Res Notes       Date:  2013-04-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.